Thursday, 21 September 2017

Cytecare appoints Dr. Mythri Shankar as Senior Consultant in Nuclear Medicine

13 July 2017 | News

With over 15 years of clinical expertise, Dr. Shankar’s experience has enabled the integration of most appropriate protocol selection while performing sophisticated radioactive injection procedures.

Cytecare, committed to revolutionise Cancer care in India, announces the appointment of a Dr. Mythri Shankar, Senior Consultant, Nuclear Medicine Department.

Dr. Mythri Shankar has trained extensively in Nuclear Medicine from various globally renowned institutions such as UCLA, Cedars Sinai, Children's Hospital of Los Angeles, and Harvard Medical School. With over 15 years of clinical expertise, Dr. Shankar’s experience has enabled the integration of most appropriate protocol selection while performing sophisticated radioactive injection procedures. She is a member of several international organizations such as the American Society of Nuclear Cardiology and the Society of Nuclear Medicine (USA & India), and is also actively involved in academics and several research projects.

Additionally, as a Physician, she is a renowned Women’s Health Activist, an entrepreneur (IIM-B Alumini) and the Founder Trustee of ‘Osteoporosis Foundation, India’.

Commenting on the appointment, Suresh Ramu, CEO & Co Founder, Cytecare Hospitals, said “We are delighted to have Dr. Mythri Shankar on board as our Nuclear Medicine specialist. Targeted therapy with radiopharmaceuticals - radioactive compounds used in nuclear medicine for diagnosis or treatment has demonstrated superior clinical outcomes in trials for cancer treatment,”.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does primary healthcare in India needs prioritization?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls